This roundtable series reviews the use of Bruton’s tyrosine kinase inhibition as front-line treatment for patients with chronic lymphocytic leukemia discussed in virtual live events.
Part 1: Sandoval Sus Discusses Recommended Treatments for a Patient With CLL
December 13th 2021During a live virtual event, Jose Sandoval Sus, MD, discussed with participating physicians frontline recommended treatment options for patients with chronic lymphocytic leukemia based on a case scenario, with questions by Targeted Oncology.